Congress Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.36M Buy
5,359
+1,454
+37% +$339K 0.01% 295
2026
Q1
$954K Sell
3,905
-488
-11% -$114K 0.01% 338
2025
Q4
$909K Sell
4,393
-70
-2% -$13.8K 0.01% 316
2025
Q3
$828K Sell
4,463
-185
-4% -$31.7K 0.01% 330
2025
Q2
$710K Sell
4,648
-111
-2% -$17.1K ﹤0.01% 329
2025
Q1
$789K Sell
4,759
-3,852
-45% -$603K 0.01% 313
2024
Q4
$1.25M Sell
8,611
-1,083
-11% -$168K 0.01% 302
2024
Q3
$1.57M Sell
9,694
-5,783
-37% -$921K 0.01% 288
2024
Q2
$2.26M Sell
15,477
-3,055
-16% -$454K 0.02% 272
2024
Q1
$2.93M Sell
18,532
-72,941
-80% -$11.6M 0.02% 257
2023
Q4
$14.3M Sell
91,473
-7,782
-8% -$1.19M 0.11% 141
2023
Q3
$15.5M Sell
99,255
-209
-0.2% -$34.5K 0.14% 132
2023
Q2
$16.5M Buy
99,464
+341
+0.3% +$55K 0.14% 128
2023
Q1
$15.4M Sell
99,123
-1,445
-1% -$233K 0.14% 130
2022
Q4
$17.8M Buy
100,568
+3,335
+3% +$576K 0.18% 104
2022
Q3
$15.9M Buy
97,233
+137
+0.1% +$23.2K 0.17% 101
2022
Q2
$17.2M Buy
97,096
+2,943
+3% +$524K 0.17% 101
2022
Q1
$16.7M Sell
94,153
-3,840
-4% -$653K 0.14% 106
2021
Q4
$16.8M Sell
97,993
-149
-0.2% -$24.4K 0.13% 101
2021
Q3
$15.8M Buy
98,142
+3,926
+4% +$670K 0.12% 103
2021
Q2
$15.5M Sell
94,216
-347
-0.4% -$57.4K 0.13% 96
2021
Q1
$15.5M Buy
94,563
+2,388
+3% +$386K 0.14% 93
2020
Q4
$14.5M Buy
92,175
+3,917
+4% +$578K 0.14% 93
2020
Q3
$13.1M Buy
88,258
+2,010
+2% +$297K 0.14% 92
2020
Q2
$12.1M Buy
86,248
+34
+0% +$4.96K 0.14% 89
2020
Q1
$11.3M Buy
86,214
+2,921
+4% +$414K 0.17% 85
2019
Q4
$12.2M Buy
83,293
+2,681
+3% +$364K 0.15% 88
2019
Q3
$10.4M Sell
80,612
-5,840
-7% -$769K 0.13% 89
2019
Q2
$12M Buy
86,452
+343
+0.4% +$47.5K 0.15% 87
2019
Q1
$12M Sell
86,109
-1,280
-1% -$171K 0.16% 85
2018
Q4
$11.3M Buy
87,389
+715
+0.8% +$99.7K 0.17% 86
2018
Q3
$12M Buy
86,674
+2,294
+3% +$305K 0.15% 90
2018
Q2
$10.2M Buy
84,380
+710
+0.8% +$88.6K 0.14% 97
2018
Q1
$10.7M Buy
83,670
+298
+0.4% +$40.3K 0.15% 91
2017
Q4
$11.6M Buy
83,372
+65
+0.1% +$9.05K 0.17% 89
2017
Q3
$10.8M Sell
83,307
-837
-1% -$111K 0.17% 87
2017
Q2
$11.1M Buy
84,144
+1,302
+2% +$166K 0.2% 83
2017
Q1
$10.3M Sell
82,842
-910
-1% -$109K 0.2% 85
2016
Q4
$9.65M Buy
83,752
+1,107
+1% +$128K 0.2% 88
2016
Q3
$9.76M Buy
82,645
+2,474
+3% +$300K 0.22% 86
2016
Q2
$9.72M Buy
80,171
+524
+0.7% +$59.5K 0.22% 86
2016
Q1
$8.62M Sell
79,647
-2,445
-3% -$253K 0.21% 94
2015
Q4
$8.43M Buy
82,092
+193
+0.2% +$19.4K 0.21% 94
2015
Q3
$7.64M Sell
81,899
-6,913
-8% -$669K 0.2% 100
2015
Q2
$8.66M Sell
88,812
-513,686
-85% -$51.4M 0.25% 99
2015
Q1
$60.6M Sell
602,498
-38,737
-6% -$3.94M 1.45% 20
2014
Q4
$67.1M Sell
641,235
-19,644
-3% -$2.07M 1.71% 11
2014
Q3
$70.4M Sell
660,879
-23,847
-3% -$2.47M 1.81% 4
2014
Q2
$71.6M Sell
684,726
-64,377
-9% -$6.51M 1.82% 10
2014
Q1
$73.6M Sell
749,103
-31,514
-4% -$2.92M 1.84% 12
2013
Q4
$71.5M Sell
780,617
-14,981
-2% -$1.38M 1.87% 21
2013
Q3
$69M Sell
795,598
-26,089
-3% -$2.34M 1.93% 9
2013
Q2
$70.5M Buy
+821,687
New +$69.7M 2.09% 3

Other funds holding JNJ

Congress Asset Management's JNJ Position: Q2 2026 in Review

Congress Asset Management increased its Johnson & Johnson (JNJ) stake by 37% in Q2 2026, buying an estimated $339K and bringing the position to 5,359 shares worth $1.36M. The position accounts for 0.01% of the portfolio, ranked #295.

Congress Asset Management first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $73.6M in Q1 2014. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Congress Asset Management held 5,359 shares of Johnson & Johnson worth $1.36M as of Q2 2026.
  • Congress Asset Management bought 1,454 Johnson & Johnson shares in Q2 2026, an estimated $339K.
  • Johnson & Johnson made up 0.01% of Congress Asset Management's portfolio in Q2 2026, its #295 holding.
  • Congress Asset Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Congress Asset Management's Johnson & Johnson position peaked at $73.6M in Q1 2014.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Congress Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.